Oral Anti-Amyloid Has the Potential to Change Disease.

Published Date: 29 Apr 2023

In a phase 2 trial, the use of ALZ-801, an improved tramiprosate prodrug, resulted in a notable decrease in plasma p-tau181, a slowing of hippocampal atrophy, and the stabilization of cognition.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Common intracellular toxin could help fight leukemia

2.

CAR T-Cell Therapy Shows Promise in Mantle Cell Lymphoma

3.

Scholastic performance is a key concern for young cancer patients, study finds

4.

AACR: American Association for Cancer Research

5.

Lung Cancer Screening Rates in Eligible Adults Remain Low, Uneven


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot